Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Astragalus Membranaceus in Mild-to-Moderate Alzheimer's Disease
NCT06694597Phase 2Completed
- Sponsor
- Fujian Medical University Union Hospital
- Start
- May 2023
- Primary completion
- Mar 2024
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
A Phase 2 trial of astragalus membranaceus in Alzheimer's disease (AD), sponsored by Fujian Medical University Union Hospital. Started May 2023; status: completed.
02
Drugs
astragalus membranaceus
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT06694597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06694597.